Battling and Beating Cancer

Everyone knows that October is Breast Cancer Awareness Month. Virtually no family has escaped being impacted by breast cancer. There are many types of breast cancer and an alarming number of young women are afflicted with breast cancer. The subject of young women and breast cancer does not receive nearly enough attention and much more public awareness and education are needed. Accordingly, on this episode of “Battling and Beating Cancer” we focus on young women with breast cancer. One of the many things that breast cancer – and other cancers – and cancer treatments can take from young women is the ability to have children. We will address the important subjects of infertility and preserving the ability of cancer patients to become mothers with Mindy Berkson, a renowned fertility consultant and founder of Chicago-based Lotus Blossom Consulting. We also will be joined by Alice Crisci, a remarkably woman who took her experience with breast cancer and turned it into a blessing for many other woman by helping them become mothers through her non-profit organization Fertile Action. This is a must hear pink episode of Battling and Beating Cancer.

This epidode of Battling & Beating Cancer is the continuation of the live broadcast of this extraordinary follicular lymphoma super-symposium presented by Chicago Blood Cancer Foundation, Rush University Medical Center, and Hope For Lymphoma and comes to you live from Chicago. Chaired by Dr. Stephanie Gregory, this conference features 10 leading world class lymphoma clinicians and researchers. You will be armed with basic and advanced information on follicular lymphoma; state of the art information; next generation treatments; and transformational insights to help you understand this disease, select optimal treatments, and empower you with strategies to survive and thrive as a follicular lymphoma survivor. Visit www.road2cure.com or www.chicagobloodcancer.org for the agenda, speaker bios, and more information.

In this episode of “Battling And Beating Cancer” we tackle the critical issue of what causes lymphoma, as world renowned cancer researchers from InterLymph joinCharlene and Scottto discuss their cutting edge research on the epidemiology of lymphoma.
The International Lymphoma Epidemiology Consortium (InterLymph)is an international group of leading medical investigators engaged in research on the epidemiology (causation) of non-Hodgkin lymphoma. One of the most common questions we hear is “what causes lymphoma” or “what causes cancer.” Curiosity may kill a cat, but a better understanding of “what causes cancer” will save untold lives through prevention and better treatments. Further, collaboration among leading researchers across the globe benefits all of us by accelerating the advancement of medical knowledge and more effective treatments.
Joining us will be esteemed medical researchers: Dennis Weisenburger, Universityof Nebraska; Tina Clarke, Cancer Prevention Institute of California; Sophia Wang, City of Hope; and Claire Vajdic, University of South Wales. These researchers share insights in advance of InterLymph's annual meeting.
Chicago Blood Cancer Foundation and Lymphoma Coalition have joined forces to bring together this international panel. “Causation” and “collaboration” are the key words on this episode of “Battling And Beating Cancer.”

On this episode of Battling And Beating Cancer we discuss maintenance therapy for lymphomas. The availability of important new therapies with minimal side effects over the past several years has provided patients and their physicians with more options. But how effective is maintenance therapy and does it limit your options down the road? Weighing the potential benefits and risks of maintenance therapy is not always easy. Dr. John Seymour, Head of the Department of Haematology at the Peter MacCallum Cancer Centre in Melbourne, Victoria, Australia, joins Scott and Charlene to discuss maintenance therapy for lymphomas. Dr. Seymour recently received the Distinguished Alumnus Award from the University of Texas MD Anderson Cancer Center.
Chicago Blood Cancer Foundation and Lymphoma Coalition have joined forces to bring you this important episode of Battling And Beating Cancer.

Season 3 ofBattling and Beating Cancer gets off to a compelling start by discussing Clinical Trials, Why They Are Safe & Important For Patients. Many patients feel that, by participating in clinical trials they will be used as Guinea pigs. The reality is that, in today's clinical trials, patients are well- monitored and generally receive the standard of care for their disease as well as an additional agent or agents that have demonstrated some degree of effectiveness. Many people are alive today because they participated in clinical trials. Dr. Julie Vose, Chief of the Division of Hematology Oncology and Professor of Medicine, University of Nebraska Medical Center, joins Charlene and Scott and helps to separate the fact from the fiction regarding clinical trials. We also will be joined by Greg Dafoe, a lymphoma survivor and moderator of the NHL Cyberfamily Support Group. Greg will discuss his participation in a clinical trial.
Chicago Blood Cancer Foundation and Lymphoma Coalition have joined forces to bring you this episode of Battling and Beating Cancer.